EndoRISE
EndoRISE
A community to advance Endometriosis Research, Innovation, Support & Education
EndoRISE is a groundbreaking, state supported initiative to address Endometriosis, a highly invasive, under-diagnosed and under-researched disease.
Seeking to improve awareness and health outcomes in Connecticut, while driving research breakthroughs that will impact women across the nation and beyond, the EndoRISE program's multifaceted approach includes:
  • The creation of the CT Data and Biorepository, a diverse data and specimen biorepository to enable research, clinical and industry collaborations
  • The education of healthcare providers, students and frontline professionals about endometriosis diagnosis and best practices
  • Serving as a centralized resource, to disseminate information and raise public awareness about the disease
Whether a patient, researcher, provider, or simply interested in learning more, we welcome you to join us in the effort to impact the lives of the over 200 million people suffering from this disease.

Public

Learn more about Endometriosis, who it effects, and the importance of raising awareness of the disease for early detection and advancements in health outcomes for those suffering from it.
Learn more

Patients

Find information, resources and community. Learn more about how you can help advance EndoRISE efforts towards better diagnostics, treatments and cures.
Learn more

Researchers

Learn more about the CT Data and Biorepository and its efforts to foster basic research and clinical collaborations designed to help advance our understanding of Endometriosis towards better diagnostics, treatments and cures.
Learn more

Providers

Learn more about Endometriosis, best practices in patient care, and the role you can play the effort to advance diagnostics, treatments and cures.
Learn more
Recent News
Screenshot 2024-10-28 at 9.38.49 AM.png
October 24, 2024
ARPA-H released an announcement of Spring for Women's Health awardees with three awardees focusing on development of endometriosis treatments and detection.
• Aspira Women's Health, based out of Shelton, CT received $10M for the development of a non-invasive endometriosis blood test.
• Nura Health, Inc., Los Angeles, CA received $3M in the aim of developing a highly characterized non-invasive, multi-omic diagnostic signature for endometriosis detection.
•Washington State University, St. Louis, MO received $3.4M for a development of a blood test that deciphers unique molecular pain signatures to diagnose and manage chronic pain conditions, including endometriosis.



Read more
Screenshot 2024-09-09 at 11.18.18 AM.png
September 09, 2024
WNPR feature story highlighting Connecticut and EndoRISE in our pioneering efforts on endometriosis awareness and research. Read and share the full article!

Read more
Upcoming and recent events
  • Endometriosis | Beyond the Lesion: Charting New Paths
    Endometriosis | Beyond the Lesion: Charting New Paths
    · August 19, 2024
    Join the Office of Research on Women’s Health (ORWH) for Beyond the Lesion: Charting New Paths, the second event of the NIH Women’s Health Roundtable Series. This series focuses on important women’s health topics, such as endometriosis, as part of the White House Women’s Health Research Initiative.
  • Endometriosis Awareness Community Event
    Endometriosis Awareness Community Event
    · October 18, 2024
    Cal State LA is hosting a community event for endometriosis awareness. The Endo What? documentary, "Below the Belt" will be screening at the event.
    October 18th 2024, 5pm-9pm

    Registration is open.
  • Continuing Medical Education (CME)
    Continuing Medical Education (CME)
    · November 15, 2024
    Join us for our upcoming CME event with world-renowned gynecologist sonographer Dr. Exacoustos.
Contact Us
For more information on EndoRISE or the biorepository, please complete the form below to get in touch with someone from the program. Click here to request samples.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.